Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Vortex Biosciences
company
About
Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering.
- Menlo Park,California,United States
- 11 - 50
Details
- Last Funding Type
- Corporate Round
- Last Funding Money Raised
- £300K
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2012
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering and informatics to deliver better tools for isolating and characterizing circulating tumor cells (CTCs). Vortex’s first product, the VTX-1 Liquid Biopsy System, automates the label free isolation and collection of viable CTCs directly from whole blood.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
£2.30M
Vortex Biosciences has raised a total of
£2.30M
in funding over 2 rounds. Their latest funding was raised on
Aug 16, 2022 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 16, 2022 | Debt Financing | £2M | 1 |
NetScientific PLC
|
— | Detail |
| May 6, 2022 | Corporate Round | £300K | 1 |
NetScientific PLC
|
— | Detail |
| Mar 22, 2019 | Series A | — | 1 |
EMV Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
3
2
Vortex Biosciences is funded by 2 investors.
NetScientific PLC
and EMV Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
NetScientific PLC
|
Yes | Debt Financing |
|
EMV Capital
|
Yes | Series A |
Employee Profiles
Number of Employee Profiles
3
Vortex Biosciences has 3 current employee profiles, including
Executive Robert Englert
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
